W. Park

OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study

Dae‐Hyun Yoo, Artur Racewicz, Jan Brzezicki et al. · Annals of the Rheumatic Diseases · 2013 · 28 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

FRI0421 A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study

W. Park, Janusz Jaworski, Jan Brzezicki et al. · Annals of the Rheumatic Diseases · 2013 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +11

OP0167 A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis

W. Park, Paweł Hrycaj, Volodymyr Kovalenko et al. · Annals of the Rheumatic Diseases · 2012 · 18 citations

Medicine, Pharmacology, Pharmacotherapy +17

AB0501 Efficacy and safety of certolizumab pegol (CZP) with concomitant methotrexate (MTX) in korean rheumatoid arthritis (RA) patients (PTS) with an inadequate response to MTX

Young Mo Kang, W. Park, Y.E. Park et al. · Annals of the Rheumatic Diseases · 2012 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +15